1379P A phase Ib study of a single priming dose of 177Lu-PSMA-617 coupled with pembrolizumab in metastatic castration resistant prostate cancer (mCRPC) R Aggarwal, L Trihy, EH Romero, SL Sam, M Rastogi, I De Kouchkovsky, ... Annals of Oncology 33, S1173, 2022 | 3 | 2022 |
1404P A phase II study of ZEN-3694 (ZEN), enzalutamide (ENZ), and pembrolizumab (P) in metastatic castration resistant prostate cancer (mCRPC): Interim safety results T Jindal, H Han, PS Deshmukh, I De Kouchkovsky, D Kwon, HT Borno, ... Annals of Oncology 33, S1187, 2022 | 1 | 2022 |
1571P COVID-19 positivity rates in patients with an active cancer diagnosis in the University of California Cancer Consortium J Hong, HT Borno, O Harismendy, S Yousefi, P Cinar, HS Rugo, MO Kim, ... Annals of Oncology 32, S1135, 2021 | | 2021 |
1751P Impact of squamous histology on clinical outcomes and molecular profiling in metastatic urothelial carcinoma (mUC) patients (pts) treated with newer therapies PS Deshmukh, I De Kouchkovsky, L Zhang, T Jindal, K Reyes, ... Annals of Oncology 33, S1338-S1339, 2022 | | 2022 |
A bilingual, Internet-based, targeted advertising campaign for prostate cancer clinical trials: assessing the feasibility, acceptability, and efficacy of a novel recruitment … CP Kaplan, A Siegel, Y Leykin, NR Palmer, H Borno, J Bielenberg, ... Contemporary Clinical Trials Communications 12, 60-67, 2018 | 11 | 2018 |
A step towards equitable clinical trial recruitment: a protocol for the development and preliminary testing of an online prostate cancer health information and clinical trial … HT Borno, BM Bakke, C Kaplan, A Hebig-Prophet, J Chao, YJ Kim, ... Pilot and feasibility studies 5, 1-8, 2019 | 8 | 2019 |
Abstract A081: Trial Library: A pilot study to examine feasibility, acceptability, and preliminary estimates of efficacy for an online clinical trial matching website on … HT Borno, B Bakke, AH Prophet, YJ Kim, J Yaeger, J Chao, P Cinar, ... Cancer Epidemiology, Biomarkers & Prevention 29 (6_Supplement_1), A081-A081, 2020 | | 2020 |
Abstract C053: Testicular cancer in Hispanics: Incidence of subtypes over time according to neighborhood sociodemographic factors in California MC DeRouen, M McKinley, SA Shah, HT Borno, R Aoki, DY Lichtensztajn, ... Cancer Epidemiology, Biomarkers & Prevention 29 (6_Supplement_2), C053-C053, 2020 | | 2020 |
Abstract D067: The REACT study: A feasibility study to develop and test the integration of a California Cancer Registry Early Case Ascertainment process via electronic … HT Borno, C Duffy, S Zhang, T Golden, Z Loya, D Oh, A Odisho, ... Cancer Epidemiology, Biomarkers & Prevention 29 (6_Supplement_2), D067-D067, 2020 | | 2020 |
Abstract PO-276: Lazarex Cancer Foundation (LCF) financial reimbursement programs (FRP) promote equitable access and inclusion among racial/ethnic minorities in therapeutic … DL Dornsife, H Borno, D Spicer, RG Johnson Cancer Epidemiology, Biomarkers & Prevention 29 (12_Supplement), PO-276-PO-276, 2020 | 1 | 2020 |
Accelerating cancer clinical trial recruitment through a financial reimbursement program integrated with patient navigation: an interrupted time series analysis HT Borno, TK Lin, S Zhang, A Skafel, A Lalanne, D Dornsife, R Johnson, ... Journal of Cancer Policy 30, 100305, 2021 | 17 | 2021 |
Advancing Equity in Oncology: Innovative Approaches and Robust Frameworks to Address Cancer Health Disparities M LaPelusa, H Khan, C Deville, SL Washington, HT Borno International Journal of Cancer Care and Delivery 3 (1), 2023 | | 2023 |
All men are created equal: addressing disparities in prostate cancer care H Borno, DJ George, LE Schnipper, F Cavalli, T Cerny, S Gillessen American Society of Clinical Oncology Educational Book 39, 302-308, 2019 | 31 | 2019 |
An electronic registry to improve adherence to active surveillance monitoring among men with prostate cancer at a safety-net hospital: protocol for a pilot study B Cedars, S Lisker, HT Borno, P Kamal, B Breyer, U Sarkar Pilot and feasibility studies 5, 1-7, 2019 | 4 | 2019 |
An unusual manifestation of diabetic ketoacidosis and acute colonic pseudo-obstruction J Natalini, H Borno, L Jin, T Jensen JRSM open 8 (6), 2054270417698632, 2017 | 4 | 2017 |
Analysis of Serious Adverse Event Reporting for Patients Enrolled in Cancer Clinical Trials During the COVID-19 Pandemic MV Ragavan, N Legaspi, A LaLanne, JC Hong, EJ Small, HT Borno JAMA oncology 8 (12), 1849-1851, 2022 | 4 | 2022 |
Androgen deprivation therapy and risk of SARS-CoV-2 infection in men with prostate cancer: A University of California (UC) Health System registry study. D Kwon, R Vashisht, H Borno, RR Aggarwal, EJ Small, A Butte, ... Journal of Clinical Oncology 39 (6_suppl), 37-37, 2021 | 6 | 2021 |
Androgen-deprivation therapy and SARS-CoV-2 in men with prostate cancer: findings from the University of California Health System registry DH Kwon, R Vashisht, HT Borno, RR Aggarwal, EJ Small, AJ Butte, ... Annals of Oncology 32 (5), 678-679, 2021 | 18 | 2021 |
Apalutamide and its use in the treatment of prostate cancer HT Borno, EJ Small Future Oncology 15 (6), 591-599, 2019 | 9 | 2019 |
Assessing Clinician Attitudes and Beliefs Around Financial Toxicity Screening in Medical Oncology Clinic ST Zhang, EJ Philip, N Legaspi, L Ding, TK Lin, HT Borno J Clin Pathways 7 (4), 43-47, 2021 | | 2021 |